Anzeige
Mehr »
Login
Mittwoch, 11.12.2024 Börsentäglich über 12.000 News von 683 internationalen Medien
Geheimtipp: Erstmals seit 150 Jahren - Neuer "Rockefeller-Moment" im Rohstoffsektor!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DJSH | ISIN: KYG9887T1168 | Ticker-Symbol: 1ZLB
Siehe auch ZAI LAB LTD ADR
Stuttgart
11.12.24
08:11 Uhr
2,620 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
ZAI LAB LTD Chart 1 Jahr
5-Tage-Chart
ZAI LAB LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,4802,74017:48
2,5202,78015:30

Aktuelle News zur ZAI LAB Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.12.ZAI LAB (09688): GRANT OF RESTRICTED SHARE UNITS4
02.12.Zai Lab, Novocure Report Positive Topline Results From Phase 3 PANOVA-3 Trial Of TTFields Therapy231BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Zai Lab (ZLAB) and Novocure (NVCR) announced that the Phase 3 PANOVA-3 trial met its primary endpoint, showing a statistically significant improvement in...
► Artikel lesen
02.12.Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer205PANOVA-3 met its primary endpoint with a statistically significant improvement in overall survival for patients with unresectable, locally advanced pancreatic adenocarcinoma treated in the first-line...
► Artikel lesen
28.11.Zai Lab's AUGTYRO For ROS1+ NSCLC Added To China's National Reimbursement Drug List296BEIJING (dpa-AFX) - Zai Lab Limited (ZLAB) announced the inclusion of AUGTYRO (repotrectinib) in China's National Reimbursement Drug List for ROS1+ non-small cell lung cancer or NSCLC. The company...
► Artikel lesen
22.11.As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact32
22.11.ZAI LAB (09688): VOLUNTARY ANNOUNCEMENT - CLOSING OF THE OFFERING OF AMERICAN DEPOSITARY SHARES AND FULL EXERCISE OF THE OPTION-
ZAI LAB Aktie jetzt für 0€ handeln
22.11.Zai Lab and Pfizer to commercialise XACDURO in China37
19.11.ZAI LAB (09688): GRANT OF RESTRICTED SHARE UNITS2
19.11.ZAI LAB (09688): NEXT DAY DISCLOSURE RETURN1
18.11.ZAI LAB (09688): OVERSEAS REGULATORY ANNOUNCEMENT - FINAL PROSPECTUS SUPPLEMENT3
15.11.Zai Lab Ltd - 8-K, Current Report1
15.11.Why Zai Lab (ZLAB) Stock Is Trading Higher2
15.11.Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday20
15.11.Zai Lab Prices Public Offering Of About 7.84 Mln ADSs At US$25.50/ADS485BEIJING (dpa-AFX) - Zai Lab Limited (ZLAB) announced the pricing of its underwritten public offering of about 7.84 million American depositary shares, each representing ten ordinary shares of...
► Artikel lesen
15.11.ZAI LAB (09688): OFFERING OF AMERICAN DEPOSITARY SHARES AND ISSUANCE OF UNDERLYING SHARES UNDER GENERAL MANDATE5
14.11.ZAI LAB (09688): OVERSEAS REGULATORY ANNOUNCEMENT - PRELIMINARY PROSPECTUS SUPPLEMENT8
14.11.ZAI LAB (09688): VOLUNTARY ANNOUNCEMENT - PROPOSED FOLLOW-ON OFFERING OF AMERICAN DEPOSITARY SHARES1
14.11.ZAI LAB (09688): OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K1
14.11.listed shares of Zai Lab slide after commencing $200 million stock offering10
12.11.Zai Lab Ltd reports results for the quarter - Earnings Summary3
Seite:  Weiter >>
79 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1